Skip to Content


UK matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Category

Lipid lowering: Fibrate

Chemical Name

Propanoic acid, 2-[4-(2,2-dichlorocyclopropyl)phenoxy]-2-metyl-

Foreign Names

  • Ciprofibratum (Latin)
  • Ciprofibrat (German)
  • Ciprofibrate (French)
  • Ciprofibrato (Spanish)

Generic Names

  • Ciprofibrate (OS: USAN, DCF, BAN)
  • Win 35833 (IS: Winthrop)
  • Ciprofibrate (PH: BP 2016, Ph. Eur. 8)
  • Ciprofibratum (PH: Ph. Eur. 8)

Brand Names

  • Cerolip
    Difare, Ecuador
  • Cetaxin
    AC Farma, Peru
  • Cibrato
    Mantecorp, Brazil
  • Ciprofibraat
    NRIM, Netherlands
  • Ciprofibrate Arrow
    Arrow, France
  • Ciprofibrate Biogaran
    Biogaran, France
  • Ciprofibrate Mylan
    Mylan, Belgium; Mylan, France
  • Ciprofibrate Sandoz
    Sandoz, France
  • Ciprofibrate Teva
    Teva Santé, France
  • Ciprofibrate Zentiva
    Sanofi-Aventis, France; Zentiva, United Kingdom
  • Ciprofibrato Farmandina
    Farmandina, Guatemala
  • Ciprofibrato Genfar
    Genfar, Colombia
  • Ciprofibrato La Santé
    La Santé, Colombia; La Santé, Costa Rica; La Santé, Nicaragua; La Santé, El Salvador
  • Ciprofibrato MK
    MK, Colombia
  • Ciprofibrato PL
    Paill, El Salvador
  • Dublina
    Pharma Investi de Chile, Chile
  • Estabinol
    Panalab, Peru
  • Estaprol
    Sanofi Aventis, Chile; Sanofi-Aventis, Argentina
  • Fibrolip
    Garmisch, Colombia
  • Fixeril
    Lazar, Argentina
  • Floxar SR
    Joswe Medical, Lebanon
  • Giabri
    Merck, Chile; Merck, Ecuador
  • Hiperlipen
    Sanofi, Dominican Republic; Sanofi, Guatemala; Sanofi, Panama; Sanofi-Aventis, Colombia; Sanofi-Aventis, Ecuador; Sanofi-Aventis, Honduras; Sanofi-Aventis, Nicaragua; Sanofi-Aventis, Peru; Sanofi-Aventis, El Salvador
  • Hyperlipen
    Sanofi Belgium, Belgium
  • Lipanor
    CTS, Israel; Sanofi Aventis, Tunisia; Sanofi Winthrop, Serbia; Sanofi-Aventis, Bosnia & Herzegowina; Sanofi-Aventis, Bulgaria; Sanofi-Aventis, France; Sanofi-Aventis, Hungary; Sanofi-Aventis, Lithuania; Sanofi-Aventis, Poland; Sanofi-Aventis, Portugal
  • Lipless
    Biolabfarma, Brazil
  • Lipobrand
    PharmaBrand, Ecuador
  • Lipodex
    Unipharm, Guatemala; Unipharm, Honduras; Unipharm, Nicaragua; Unipharm, El Salvador
  • Modalim
    Sanofi Aventis, China; Sanofi-Aventis, Indonesia; Sanofi-Aventis, Malaysia; Sanofi-Aventis, Netherlands; Sanofi-Aventis, Philippines; Sanofi-Aventis, Singapore; Sanofi-Synthelabo, Lebanon
  • Oroxadin
    Sanofi Aventis, Brazil; Sanofi-Aventis, Mexico


BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.